Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Moodys
Colorcon
Merck
Harvard Business School
Medtronic

Last Updated: November 20, 2019

DrugPatentWatch Database Preview

Litigation Details for Arena Pharmaceuticals Inc. v. Lupin Ltd. (D. Del. 2016)

See Plans and Pricing

« Back to Dashboard

Arena Pharmaceuticals Inc. v. Lupin Ltd. (D. Del. 2016)

Docket   Start Trial Date Filed 2016-09-30
Court District Court, D. Delaware Date Terminated 2019-04-04
Cause 35:271 Patent Infringement Assigned To Richard Gibson Andrews
Jury Demand None Referred To
Parties API DEVELOPMENT LTD; ARENA PHARMACEUTICALS GMBH; ARENA PHARMACEUTICALS INC.; EISAI INC.; LUPIN LTD.; LUPIN PHARMACEUTICALS INC.; TEVA PHARMACEUTICALS USA INC.
Patents 6,953,787; 7,514,422; 7,977,329; 8,207,158; 8,273,734; 8,546,379; 8,575,149; 8,999,970; 9,169,213; 9,770,455
Attorneys Andrea L. Cheek; Anthony David Raucci; Bruce M. Wexler; Carol M. Pitzel Cruz; Christie R.W. Matthaei; David A. Bilson; Jack B. Blumenfeld; John C. Phillips , Jr.; Jonathan E. Bachand; Julia M. Johnson; Karen Elizabeth Keller; Katherine D. Hundt; Loni L. Morrow; Maryellen Noreika; Melanie R. Rupert; Michael A. Meneghini; Nathan Roger Hoeschen; Shilpa A. Coorg; Simon F. Kung; William R. Zimmerman; Young J. Park
Firms Morris, Nichols, Arsht & Tunnell; Phillips, Goldman, McLaughlin & Hall, P.A.; Shaw Keller LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Arena Pharmaceuticals Inc. v. Lupin Ltd.
The small molecule drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for Arena Pharmaceuticals Inc. v. Lupin Ltd. (D. Del. 2016)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 109 Notice of Service Disclosure of Invalidity Contentions for U.S. Patent No. 9,770,455 filed by Lupin Ltd., Lupin Pharmaceuticals…2016 4 April 2019 1:16-cv-00887 830 Patent None District Court, D. Delaware External link to document
0000-00-00 135 Regarding Lupin's Infringement of U.S. Patent Nos. 6,953,787, 7,514,422, 7,977,329, 8,207,158, 8,273,…. Regarding Teva's Infringement of U.S. Patent Nos. 6,953,787, 7,514,422, 7,977,329, 8,207,158, 8,273,…2016 4 April 2019 1:16-cv-00887 830 Patent None District Court, D. Delaware External link to document
0000-00-00 142 Judgment - Consent quot;) for infringement of United States Patent Nos. 6,953 ,787, 7,514,422, 7,977,329, 8,207,158, 8,273…JUDGMENT WHEREAS, this action for patent infringement has been brought by Plaintiffs Arena…8,273 ,734, and 9,770,455 (the "Patents" and such action, the "Litigation," and the … 2978 2. Teva has infringed the Patents pursuant to 35 U.S.C. §271(e)(2) by filing Abbreviated…Affiliates, until any grant of license to the Patents provided in the Settlement Agreement to Teva becomes External link to document
2019-04-04 155 Judgment - Consent for infringement of United States Patent Nos . 6,953 ,787, 7,514,422, 7,977,329, 8,207,158, 8,273… WHEREAS, this action for patent infringement has been brought by Plaintiffs …8,273 ,734, and 9,770,455 (the "Patents" and such action, the "Litigation," and the… 2. Lupin has infringed the Patents pursuant to 35 U.S.C. §27l(e)(2) by filing …Affiliates, until any grant of license to the Patents provided in the Settlement Agreement to Lupin becomes External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Dow
Boehringer Ingelheim
Medtronic
Johnson and Johnson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.